Red man syndrome adverse reaction following intravenous infusion of cefepime
- PMID: 22948884
- PMCID: PMC3497189
- DOI: 10.1128/AAC.01274-12
Red man syndrome adverse reaction following intravenous infusion of cefepime
Abstract
We report the first case of cefepime-induced "red-man syndrome," which appeared 30 min following drug infusion and was confirmed with a rechallenge test. This syndrome is classically associated with vancomycin infusion and is the result of non-IgE mediated mast cell degranulation. While this adverse effect can be easily managed with drug withdrawal and antihistamine administration, it is unknown whether it can be prevented with slower cefepime infusion and preinfusion antihistamines, as is the case with vancomycin.
Figures
Similar articles
-
Vancomycin-induced red man syndrome in pediatric oncology: still an issue?Int J Clin Pharm. 2012 Feb;34(1):13-6. doi: 10.1007/s11096-011-9593-z. Epub 2011 Dec 13. Int J Clin Pharm. 2012. PMID: 22161495
-
Red man syndrome.Ann Pharmacother. 1998 Jul-Aug;32(7-8):840. doi: 10.1345/aph.16425. Ann Pharmacother. 1998. PMID: 9681102 No abstract available.
-
Vancomycin Infusion Reaction - Moving beyond "Red Man Syndrome".N Engl J Med. 2021 Apr 8;384(14):1283-1286. doi: 10.1056/NEJMp2031891. Epub 2021 Apr 3. N Engl J Med. 2021. PMID: 33830710 Free PMC article. No abstract available.
-
Comparative safety of teicoplanin and vancomycin.J Chemother. 2000 Nov;12 Suppl 5:21-5. doi: 10.1080/1120009x.2000.11782314. J Chemother. 2000. PMID: 11131960 Review.
-
Cefepime-Induced Neurotoxicity Despite Dose Adjustment for Renal Disease: A Brief Report and Review of the Literature.J Pediatric Infect Dis Soc. 2017 Jun 1;6(2):199-201. doi: 10.1093/jpids/piw022. J Pediatric Infect Dis Soc. 2017. PMID: 27147713 Review.
Cited by
-
Stevens-Johnson syndrome caused by cefepime?J Pharmacol Pharmacother. 2015 Jan-Mar;6(1):35-6. doi: 10.4103/0976-500X.149143. J Pharmacol Pharmacother. 2015. PMID: 25709351 Free PMC article. No abstract available.
References
-
- Lobel E, Korelitz B, Warman J. 2003. Red man syndrome and infliximab. J. Clin. Gastroenterol. 36:186. - PubMed
-
- Moreno E, et al. 2007. Selective immediate hypersensitivity to cefepime. J. Invest. Allergol. Clin. Immunol. 17:52–54 - PubMed
-
- Mutnick AH, Rhomberg PR, Sader HS, Jones RN. 2004. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001). J. Antimicrob. Chemother. 53:290–296 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical